Placebo Response and Media Attention in Randomized Clinical Trials Assessing Cannabis-Based Therapies for Pain
Abstract Question: What is the size of the placebo response in cannabinoid trials for clinical pain, and is the magnitude…
Free
Formulation of Nanomicelles Loaded with Cannabidiol as a Platform for Neuroprotective Therapy
Abstract The present study is focused on the development of cannabidiol-loaded polymeric nanomicelles as a drug delivery system with neuroprotective…
Association of CNR1 gene and cannabinoid 1 receptor protein in the human brain
Abstract We aimed to integrate genomic mapping from brain mRNA atlas with the protein expression from positron emission tomography (PET)…
Extension for Community Healthcare Outcomes (ECHO) Chronic Pain & Opioid Stewardship in Northwestern Ontario: A Thematic Analysis of Patient Cases
Abstract Background: Chronic pain (CP) is a debilitating disease that reduces quality of life, decreases productivity, and has become a…
A Systematic Review and Meta-Analysis on the Role of Nutraceuticals in the Management of Neuropathic Pain in In Vivo Studies
Abstract The control of neuropathic pain is a leading challenge in modern medicine. Traditional medicine has, for a long time,…
An Assessment of Vape Shop Products in California before and after Implementation of FDA and State Regulations
Abstract Vape shops specialize in sales of e-cigarettes and related products. This study examines whether vape shops adapted their products…
Synthetic cannabinoid for the treatment of severe chronic noncancer pain in children and adolescents
Abstract Background: The prevalence of chronic pain in children and adolescents is high. In some patients, it can be severe…
Effect of oral cannabis administration on the fat depots of obese and streptozotocin‐induced diabetic rats
Abstract The prevalence of obesity and insulin‐resistance is on the rise, globally. Cannabis have been shown to have anti‐diabetic/obesity properties,…
Medical cannabis-related stigma: cancer survivors’ perspectives
Abstract Background: Although the vast majority of medical cannabis laws in the USA includes cancer as a qualifying condition and…
Inhibiting Human and Leishmania Arginases Using Cannabis sativa as a Potential Therapy for Cutaneous Leishmaniasis: A Molecular Docking Study
Abstract Cutaneous leishmaniasis (CL), a vector-borne parasitic disease caused by the Leishmania protozoan, is a serious public health problem in…